Case number 1:17-cv-01129
Bayer Intellectual Property GmbH et al v. Breckenridge Pharmaceutical, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 2, 2020 | 32 | Order Dismissing Case (2) Docket Text: ORDER granting Stipulation of Dismissal [229] by Bayer and InvaGen. Signed by Judge Timothy Belcher Dyk on 9/2/2020. CASE CLOSED.Associated Cases: 1:17-cv-00462-TBD et al.(amf) |
| Feb 13, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Timothy Belcher Dyk of the United States Court of Appeals for the Federal Circuit. Please include the initials of the Judge (TBD) after the case number on all documents filed. Associated Cases: 1:17-cv-00462-TBD, 1:17-cv-00560-TBD, 1:17-cv-00584-TBD, 1:17-cv-01129-TBD, 1:18-cv-01926-TBD (rjb) |
| Nov 13, 2017 | 31 | Order (7) Docket Text: SO ORDERED Granting (26 in 17-cv-1163-RGA, 28 in 17-cv-462-RGA, 27 in 17-cv-584-RGA, 23 in 17-cv-675-RGA, 29 in 17-cv-648-RGA, 24 in 17-cv-560-RGA, 29 in 17-cv-1129-RGA, 26 in 17-cv-483-RGA, 25 in 17-cv-812-RGA, 32 in 17-cv-1047-RGA) Stipulation and Order of Consolidation. Signed by Judge Richard G. Andrews on 11/13/2017. Associated Cases: 1:17-cv-00462-RGA et al.(nms) |
| Nov 13, 2017 | 30 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Breckenridge Pharmaceutical, Inc.'s Production Pursuant to Paragraph 4(b) of the Delaware Default Standard for Discovery filed by Breckenridge Pharmaceutical, Inc..(Haney, Megan) |
| Nov 10, 2017 | 29 | Stipulation (7) Docket Text: STIPULATION and [Proposed] Order of Consolidation by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| Nov 9, 2017 | 28 | Answer to Complaint (15) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, and COUNTERCLAIMS against all Plaintiffs, by Breckenridge Pharmaceutical, Inc..(Phillips, John) Modified on 11/9/2017 (nms). |
| Nov 2, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [27] STIPULATION TO EXTEND TIME to answer, move or otherwise respond to Complaint to November 9, 2017 (*Reset Answer Deadlines: Breckenridge Pharmaceutical, Inc. answer due 11/9/2017). Signed by Judge Richard G. Andrews on 11/2/2017. (nms) |
| Nov 1, 2017 | 27 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Breckenridge to answer, move or otherwise respond to Plaintiffs' Complaint to November 9, 2017 - filed by Breckenridge Pharmaceutical, Inc.. (Phillips, John) |
| Oct 24, 2017 | 26 | Order (30) Docket Text: SO ORDERED Granting Stipulated Protective Order. Signed by Judge Richard G. Andrews on 10/24/2017. Associated Cases: 1:17-cv-00462-RGA et al.(nms) |
| Oct 23, 2017 | 25 | Proposed Order (30) Docket Text: PROPOSED Protective Order, by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 10/23/2017 (nms). |
| Oct 23, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (25 in 17-cv-462-RGA, 19 in 17-cv-675-RGA, 27 in 17-cv-1047-RGA, 26 in 17-cv-648-RGA, 23 in 17-cv-1163-RGA, 22 in 17-cv-483-RGA, 22 in 17-cv-812-RGA, 24 in 17-cv-1129-RGA, 21 in 17-cv-560-RGA, 23 in 17-cv-584-RGA) Stipulation and Order on Proposed Protective Order. Signed by Judge Richard G. Andrews on 10/23/2017. Associated Cases: 1:17-cv-00462-RGA et al.(nms) |
| Oct 20, 2017 | 24 | Stipulation (6) Docket Text: STIPULATION and Order on Proposed Protective Order, by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 10/23/2017 (nms). |
| Oct 20, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [23] STIPULATION TO EXTEND TIME to answer, move or otherwise respond to Complaint to November 2, 2017, filed by Breckenridge Pharmaceutical, Inc.. Signed by Judge Richard G. Andrews on 10/20/2017. (ksr, ) Modified on 10/23/2017 (nms). |
| Oct 19, 2017 | 23 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to answer, move or otherwise respond to Complaint to November 2, 2017 - filed by Breckenridge Pharmaceutical, Inc.. (Haney, Megan) Modified on 10/23/2017 (nms). |
| Oct 17, 2017 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The Notice of Service filed at D.I. 23 has been removed from the docket. The filing was a duplicate of the notice filed at D.I. [22]. (nms) |
| Oct 17, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (21 in 17-cv-483-RGA, 18 in 17-cv-675-RGA, 20 in 17-cv-1163-RGA, 25 in 17-cv-1047-RGA, 24 in 17-cv-648-RGA, 262 in 15-cv-902-RGA, 21 in 17-cv-1129-RGA, 22 in 17-cv-584-RGA, 20 in 17-cv-560-RGA, 23 in 17-cv-462-RGA, 20 in 17-cv-812-RGA) MOTION for Pro Hac Vice Appearance of Attorney Todd L. Krause of Sidley Austin LLP, filed by Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc., Bayer Pharma AG, Janssen Pharmaceuticals Inc., Bayer AG, Bayer Intellectual Property GMBH. Signed by Judge Richard G. Andrews on 10/17/2017. Associated Cases: 1:15-cv-00902-RGA et al.(nms) |
| Oct 16, 2017 | 22 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Breckenridge Pharmaceutical, Inc.'s Rule 26(a)(1) Initial Disclosures filed by Breckenridge Pharmaceutical, Inc..(Haney, Megan) |
| Oct 16, 2017 | 21 | Motion for Leave to Appear Pro Hac Vice (13) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Todd L. Krause of Sidley Austin LLP - filed by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc., Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Oct 13, 2017 | 20 | Notice of Service (14) Docket Text: NOTICE OF SERVICE of (1) Bayer Intellectual Property GmbH and Bayer AG's Initial Disclosures; and (2) Janssen Pharmaceuticals, Inc.'s Initial Disclosures filed by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) |
| Oct 11, 2017 | 19 | Notice of Service (14) Docket Text: NOTICE OF SERVICE of Plaintiffs Bayer Intellectual Property GmbH, Bayer AG, and Janssen Pharmaceuticals, Inc.'s Initial Identification of Asserted Patents and Accused Products filed by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) |
| Oct 3, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [18] STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to October 20, 2017 (*Reset Answer Deadlines: Breckenridge Pharmaceutical, Inc. answer due 10/20/2017). Signed by Judge Richard G. Andrews on 10/3/2017. (nms) |
| Oct 2, 2017 | 18 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Breckenridge to answer, move or otherwise respond to Plaintiffs' Complaint to October 20, 2017 - filed by Breckenridge Pharmaceutical, Inc.. (Haney, Megan) |
| Oct 2, 2017 | 17 | Scheduling Order (11) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 3/9/2018. Amended Pleadings due by 3/9/2018. Fact Discovery completed by 8/10/2018. Joint Claim Construction Brief due by 6/22/2018. A Markman Hearing is set for 7/3/2018, at 9:00 AM in Courtroom 6A before Judge Richard G. Andrews. A Pretrial Conference is set for 3/22/2019, at 9:00 AM in Courtroom 6A before Judge Richard G. Andrews. A 3 day Bench Trial is set for 4/1/2019, at 9:30 AM in Courtroom 6A before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 9/29/2017. Associated Cases: 1:17-cv-00462-RGA et al.(nms) |
| Oct 2, 2017 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:17-cv-00462-RGA et al.(cak) |
| Sep 29, 2017 | 16 | Letter (1) |
| Sep 29, 2017 | 16 | Proposed Order (11) Docket Text: PROPOSED Scheduling Order, by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc.. (Attachments: # (1) Letter)(Smith, Rodger) Modified on 9/29/2017 (nms). |
| Sep 13, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Daniel R. Evans for Breckenridge Pharmaceutical, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm) |
| Sep 12, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Christopher J. Sorenson,B. Jefferson Boggs for Breckenridge Pharmaceutical, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm) |
| Sep 11, 2017 | 15 | Certification of Daniel R. Evans (1) |
| Sep 11, 2017 | 15 | Motion for Leave to Appear Pro Hac Vice (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Daniel R. Evans - filed by Breckenridge Pharmaceutical, Inc.. (Attachments: # (1) Certification of Daniel R. Evans)(Haney, Megan) |
| Sep 11, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [15] MOTION for Pro Hac Vice Appearance of Attorney Daniel R. Evans, filed by Breckenridge Pharmaceutical, Inc.. Signed by Judge Richard G. Andrews on 9/11/2017. (nms) |
| Sep 8, 2017 | 14 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pensa Pharma S.A. for Breckenridge Pharmaceutical, Inc. filed by Breckenridge Pharmaceutical, Inc.. (Haney, Megan) |
| Sep 8, 2017 | 13 | Certification of Christopher J. Sorenson (1) |
| Sep 8, 2017 | 13 | Certification of B. Jefferson Boggs, Jr. (1) |
| Sep 8, 2017 | 13 | Motion for Leave to Appear Pro Hac Vice (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney B. Jefferson Boggs, Jr. and Christopher J. Sorenson - filed by Breckenridge Pharmaceutical, Inc.. (Attachments: # (1) Certification of B. Jefferson Boggs, Jr., # (2) Certification of Christopher J. Sorenson)(Haney, Megan) |
| Sep 8, 2017 | 12 | Motion for Leave to Appear Pro Hac Vice (16) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Adam L. Perlman, Dov P. Grossman, Alexander S. Zolan, Martha C. Kidd and Kathryn S. Kayali - filed by Bayer AG, Bayer Intellectual Property GmbH. (Smith, Rodger) |
| Sep 8, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [13] MOTION for Pro Hac Vice Appearance of Attorney B. Jefferson Boggs, Jr. and Christopher J. Sorenson, filed by Breckenridge Pharmaceutical, Inc.. Signed by Judge Richard G. Andrews on 9/8/2017. (nms) |
| Sep 8, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (14 in 17-cv-812-RGA, 11 in 17-cv-675-RGA, 14 in 17-cv-584-RGA, 12 in 17-cv-1129-RGA, 18 in 17-cv-648-RGA, 14 in 17-cv-560-RGA, 18 in 17-cv-462-RGA, 14 in 17-cv-483-RGA, 10 in 17-cv-1163-RGA, 15 in 17-cv-1047-RGA) MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Adam L. Perlman, Dov P. Grossman, Alexander S. Zolan, Martha C. Kidd and Kathryn S. Kayali, filed by Bayer Intellectual Property GmbH, Bayer Intellectual Property GmbH, Bayer AG, Bayer Intellectual Property GMBH. Signed by Judge Richard G. Andrews on 9/8/2017. Associated Cases: 1:17-cv-00462-RGA et al.(nms) |
| Sep 7, 2017 | 11 | Proposed Order (11) Docket Text: PROPOSED Scheduling Order, by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 9/7/2017 (nms). |
| Sep 6, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Plaintiffs' Complaint to October 6, 2017 (*Reset Answer Deadlines: Breckenridge Pharmaceutical, Inc. answer due 10/6/2017). Signed by Judge Richard G. Andrews on 9/6/2017. (nms) |
| Sep 5, 2017 | 10 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Plaintiffs' Complaint to October 6, 2017 - filed by Breckenridge Pharmaceutical, Inc.. (Haney, Megan) |
| Sep 1, 2017 | 9 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Megan C. Haney on behalf of Breckenridge Pharmaceutical, Inc. (Haney, Megan) |
| Sep 1, 2017 | 8 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by John C. Phillips, Jr on behalf of Breckenridge Pharmaceutical, Inc. (Phillips, John) |
| Aug 17, 2017 | 7 | Declaration (9) Docket Text: DECLARATION of Mailing as to service on Breckenridge Pharmaceutical, Inc., by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 8/17/2017 (nms). |
| Aug 16, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Aug 14, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Breckenridge Pharmaceutical, Inc. on 8/14/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmfn) |
| Aug 11, 2017 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc. (nmfn) |
| Aug 11, 2017 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Intellectual Property GmbH filed by Bayer AG, Bayer Intellectual Property GmbH. (nmfn) |
| Aug 11, 2017 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218 B2. (nmfn) |
| Aug 11, 2017 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/30/2017. Date of Expiration of Patent: 2/17/2034.Thirty Month Stay Deadline: 1/1/2019. (nmfn) |
| Aug 11, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmfn) |
| Aug 11, 2017 | 1 | Civil Cover Sheet (1) |
| Aug 11, 2017 | 1 | Exhibit A (14) |
